Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
EverImmune launches Phase I Clinical Trial for its Oncobiotic Drug Candidate in Lung and Kidney Cancer
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the […]
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic […]
Eisai Submits Marketing Application for lecanemab for Alzheimer's
BioArctic AB’s partner Eisai announced today that Eisai has submitted a marketing authorization application for […]
Celadon Pharmaceuticals Announces Approval of GMP Registration by MHRA
Celadon Pharmaceuticals, a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of […]
Breakthrough CRISPR Technology Study Published in Nature
A groundbreaking research study by a team that included scientists from Benson Hill has been published […]
Jasper Therapeutics Announces New Positive Briquilimab Data to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Jasper Therapeutics, a biotechnology company developing novel antibody therapies addressing chronic diseases such as urticaria, […]
CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in Poland
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Novotech, the leading Asia Pacific centered biotech CRO has announced the acquisition of CBR International, […]
Theragent Secures Novel Stem Cell Bank Production Contract with Accelerated Biosciences
Theragent, a cell therapy Contract Development and Manufacturing Organization (CDMO) focused on advancing next-generation cancer […]
NHS Delivers 20 Million Flu Jabs As Critical Care Cases Rise
More than 20 million people in England have had their flu jabs as the number […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more